Capital World Investors, a registered investment adviser, initiated a new position in Amgen Inc. (NASDAQ:AMGN) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 23,097,711 shares of the Healthcare company, valued at approximately $7.6B as of the filing date.
Amgen Inc.'s stock currently trades at $365.44 with a market capitalization of $170.9B.